CDXS · Codexis, Inc. · Webcasts, Transcripts & Audio
$1.05
-0.03 (-2.78%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$118.27M
Shares
109.51M
Volume · Nov 5
870.8K
Avg daily vol (3M)
935.68K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Codexis, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Codexis, Inc. (CDXS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-12
Codexis, Inc. (CDXS) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-10
Codexis, Inc. (CDXS) September 10, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-11
Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript
Confident tone
Ecosynthesis platform progress
Commercial pipeline and partnerships
GMP manufacturing facility build-out
Revenue
$14.91M
▼ 2.7% YoY Diluted EPS
$-0.13
Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-06-17
Codexis, Inc. (CDXS) June 17, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Confident tone
Ecosynthesis platform progress
CDMO partnerships and licensing deals
Stereoisomer control capability
Revenue
$15.25M
▲ 102.1% YoY Diluted EPS
$-0.10
Gross margin
86.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Confident tone
ECOsynthesis platform progress and scaling
siRNA market opportunity and demand
Commercial partnerships and CDMO agreements
Revenue
$38.91M*
▲ 81.3% YoY Gross margin
94.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript
Confident tone
ECO Synthesis Platform / siRNA Manufacturing
Leadership Transition / Organizational Restructuring
Merck Supply Assurance Agreement
Revenue
$8.60M
▼ 33% YoY Diluted EPS
$-0.22
Gross margin
71.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript
Confident tone
ECO Synthesis platform momentum
Customer engagements and pipeline
Financial performance and guidance
Revenue
$15.33M
▲ 92.1% YoY Diluted EPS
$-0.16
Gross margin
86.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript
Confident tone
TIDES USA Presentations / CDMO Collaborators
Ligase Business Growth
siRNA Industry Momentum
Revenue
$7.54M
▼ 55.8% YoY Diluted EPS
$-0.25
Gross margin
63.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Codexis, Inc. (CDXS) Q4 2024 Earnings Call Transcript
Confident tone
ECO Synthesis commercial launch
Customer engagement and partnerships
GMP manufacturing and scale-up
Revenue
$21.46M*
▼ 19.2% YoY Gross margin
83.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript
Confident tone
ECO Synthesis Manufacturing Platform
Double-Stranded RNA Ligase
Nucleotide Building Blocks (NQP/NTP)
Revenue
$12.83M
▲ 38.3% YoY Diluted EPS
$-0.29
Gross margin
66.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript
Confident tone
ECO Synthesis Platform
Pharma Manufacturing Business
Double-Stranded RNA Ligase
Revenue
$7.98M
▼ 62.6% YoY Diluted EPS
$-0.32
Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript
Confident tone
Double-Stranded RNA Ligase Program and Screening Service
Pharma Manufacturing Customer Base and Diversification
2024 Financial Guidance Reiteration
Revenue
$17.07M
▲ 31.5% YoY Diluted EPS
$-0.16
Gross margin
71.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript
Confident tone
RNA ligase (dsRNA) commercial opportunity
Strategic licensing and partnerships
ECO Synthesis manufacturing platform
Revenue
$26.56M*
▼ 12.6% YoY Gross margin
89.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript
Revenue
$9.28M
▼ 73.1% YoY Diluted EPS
$-0.50
Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Codexis, Inc. (CDXS) Q4 2022 Earnings Call Transcript
Revenue
$30.37M*
▲ 24% YoY Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Codexis, Inc. (CDXS) Q3 2022 Earnings Call Transcript
Revenue
$34.47M
▼ 6.3% YoY Diluted EPS
$-0.15
▼ 600% YoY Gross margin
71.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Codexis, Inc. (CDXS) Q2 2022 Earnings Call Transcript
Revenue
$38.41M
▲ 50.9% YoY Diluted EPS
$-0.04
Gross margin
70.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Codexis, Inc. (CDXS) Q1 2022 Earnings Call Transcript
Revenue
$35.34M
▲ 96% YoY Diluted EPS
$-0.13
Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Codexis, Inc. (CDXS) Q4 2021 Earnings Call Transcript
Revenue
$24.50M*
▲ 16.5% YoY Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Codexis, Inc. (CDXS) Q3 2021 Earnings Call Transcript
Revenue
$36.77M
▲ 100% YoY Diluted EPS
$0.03
Gross margin
81.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Codexis, Inc. (CDXS) Q2 2021 Earnings Call Transcript
Revenue
$25.45M
▲ 70.1% YoY Diluted EPS
$-0.07
Gross margin
83.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Codexis, Inc. (CDXS) Q1 2021 Earnings Call Transcript
Revenue
$18.03M
▲ 22.9% YoY Diluted EPS
$-0.14
Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Codexis, Inc. (CDXS) Q4 2020 Earnings Call Transcript
Revenue
$21.03M*
▲ 12.8% YoY Gross margin
72.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Codexis, Inc. (CDXS) Q3 2020 Earnings Call Transcript
Revenue
$18.39M
▼ 16.1% YoY Diluted EPS
$-0.10
▼ 1100% YoY Gross margin
80.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Codexis, Inc. (CDXS) Q2 2020 Earnings Call Transcript
Revenue
$14.97M
▲ 21.5% YoY Diluted EPS
$-0.11
Gross margin
88.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Codexis, Inc. (CDXS) Q1 2020 Earnings Call Transcript
Revenue
$14.67M
▼ 5.9% YoY Diluted EPS
$-0.13
Gross margin
82.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Codexis, Inc. (CDXS) Q4 2019 Earnings Call
Revenue
$18.65M*
▲ 16.1% YoY Gross margin
81.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts
Key facts
CIK
1200375
CUSIP
192005106
13F (30d)
34 filings
34 filers
Visit website
Investor relations